Additionally, IKAROS Family Zinc Finger 1 (IKZF1) exon deletion has been reported to be associated with poorer outcomes in CML patients [81]. This evidence concerns the gene IKZF1 and chronic myelogenous leukemia, BCR-ABL1 positive.